Big Gain For Aravive, Inc.

Mon, Oct 31, 2022 at 07:28 PM
Big Gain For Aravive, Inc.

Aravive, Inc. (ARAV:NASDAQ) soared at $1.31, a gain of 23.6%. On Mon, Oct 31, 2022, ARAV:NASDAQ hit a New 2-Week High of $1.31. The stock got featured on our News Catalysts scanner on Tue, Oct 25, 2022 at 09:12 AM in the 'PRIVATE PLACEMENT' category. From Mon, Oct 17, 2022, the stock recorded 60.00% Up Days and 45.45% Green Days

About Aravive, Inc. (ARAV:NASDAQ)

Versartis Inc is an endocrine-focused biopharmaceutical company initially developing long-acting recombinant human growth hormone for the treatment of growth hormone deficiency.

Get 50% Off Premium Subscription
$19.99 USD
Limited-Time Discount
$9.99 USD
Signup 7 Days Trial. No Credit Card Required!
Ever wanted to explore stocks that have recently spiked... stocks moving sideways... gaps... or other trends? You're in the right place! Check StockTreats features.